• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于1500万例住院病例的中国首批罕见病名录现状研究

[Study on the current situation of China's First List of Rare Diseases based on 15 million hospitalizations].

作者信息

Shi X M, Liu H, Wang L, Wang Z X, Dong C Y, Wang Y F, Yao C, Zhan S Y, Ding J, Li Y

机构信息

Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2018 Oct 30;98(40):3274-3278. doi: 10.3760/cma.j.issn.0376-2491.2018.40.012.

DOI:10.3760/cma.j.issn.0376-2491.2018.40.012
PMID:30392295
Abstract

To investigate and analyze the distribution of 121 diseases of China's First List of Rare Diseases based on hospitalized patients of tertiary hospitals and to explore the current situation of rare diseases in China. Based on previous data of study from Beijing Society of Rare Diseases, a comparison between China's First List of Rare Diseases and the survey list from the pre-study was performed. Descriptive analysis was carried out on the current situation of rare diseases on hospitalizations in 96 tertiary hospitals from year of 2014 to 2015. Nineteen out of 121 diseases on China's First List of Rare Diseases were not included in the rare diseases survey list of Beijing Society of Rare Diseases. The total number of other 102 rare disease cases was 54 468, accounting for 0.35% of the inpatients during the same period. The top ten most and least cases with rare disease were demonstrated in this study. The number of the top ten most cases was 37 977, accounting for 0.25% of the inpatients during the same period. The number of the top ten least cases was 24, accounting for 0.000 16% of the inpatients during the same period. The top most five types of rare diseases counted on the provinces and municipalities were Beijing, Hunan, Shanghai, Shandong and Guangdong. The top five most cases of rare diseases counted on the provinces and municipalities were Beijing, Shanghai, Guangdong, Shandong and Hubei. The age distribution showed that the cases with rare diseases aged 25-64 years accounted for 45.8%, and the cases in children aged 0-14 accounted for 28.6%. The top ten readmission rate ranged from 28.42% to 64.88%. This study preliminarily investigates the number, type, province and municipality distribution, age distribution, and readmission rate of 121 rare diseases from China's First List of Rare Diseases in the hospitalized patients of tertiary hospitals, which provides important data for registration study, medical and drug policy making and other relevant work on rare diseases in China in the future.

摘要

基于三级医院住院患者调查分析《中国第一批罕见病目录》中121种疾病的分布情况,以探索我国罕见病的现状。基于北京罕见病学会之前的研究数据,对《中国第一批罕见病目录》和预研究的调查清单进行了比较。对2014年至2015年96家三级医院住院患者的罕见病现状进行了描述性分析。《中国第一批罕见病目录》中的121种疾病中有19种未被纳入北京罕见病学会的罕见病调查清单。其他102种罕见病病例总数为54468例,占同期住院患者的0.35%。本研究展示了罕见病病例数最多和最少的前十种疾病。病例数最多的前十种疾病有37977例,占同期住院患者的0.25%。病例数最少的前十种疾病有24例,占同期住院患者的0.00016%。按省市统计,罕见病病例数最多的前五个地区是北京、湖南、上海、山东和广东。按省市统计,罕见病病例数最多的前五个地区是北京、上海、广东、山东和湖北。年龄分布显示,25至64岁的罕见病患者占45.8%,0至14岁儿童患者占28.6%。前十种疾病的再入院率在28.42%至64.88%之间。本研究初步调查了《中国第一批罕见病目录》中121种罕见病在三级医院住院患者中的数量、类型、省市分布、年龄分布和再入院率,为我国未来罕见病登记研究、医疗和药物政策制定等相关工作提供了重要数据。

相似文献

1
[Study on the current situation of China's First List of Rare Diseases based on 15 million hospitalizations].基于1500万例住院病例的中国首批罕见病名录现状研究
Zhonghua Yi Xue Za Zhi. 2018 Oct 30;98(40):3274-3278. doi: 10.3760/cma.j.issn.0376-2491.2018.40.012.
2
Rare diseases in China: analysis of 2014-2015 hospitalization summary reports for 281 rare diseases from 96 tertiary hospitals.中国罕见病:96 家三甲医院 281 种罕见病 2014-2015 年住院汇总分析报告
Orphanet J Rare Dis. 2019 Jul 1;14(1):160. doi: 10.1186/s13023-019-1137-y.
3
China's innovation and research contribution to combating neglected diseases: a secondary analysis of China's public research data.中国在防治被忽视疾病方面的创新和研究贡献:对中国公共研究数据的二次分析。
Glob Health Res Policy. 2023 Mar 14;8(1):6. doi: 10.1186/s41256-023-00288-0.
4
Current Status of the Health Information Technology Industry in China from the China Hospital Information Network Conference: Cross-sectional Study of Participating Companies.中国医院信息网络大会视角下中国医疗卫生信息技术产业的现状:对参会公司的横断面研究
JMIR Med Inform. 2022 Jan 11;10(1):e33600. doi: 10.2196/33600.
5
[Malaria situation in the People's Republic of China in 2002].[2002年中华人民共和国疟疾疫情]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2003;21(4):193-6.
6
Expanding public health in China: an empirical analysis of healthcare inputs and outputs.中国公共卫生的扩展:医疗投入与产出的实证分析。
Public Health. 2017 Jan;142:73-84. doi: 10.1016/j.puhe.2016.10.007. Epub 2016 Nov 22.
7
Medical evacuation management and clinical characteristics of 3,255 inpatients after the 2010 Yushu earthquake in China.中国玉树 2010 年地震后 3255 例住院患者的医疗后送管理和临床特征。
J Trauma Acute Care Surg. 2012 Jun;72(6):1626-33. doi: 10.1097/TA.0b013e3182479e07.
8
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
9
[Malaria situation in the People's Republic of China in 2003].[2003年中华人民共和国疟疾疫情]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005 Dec 30;23(6):385-7.
10
Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition).国家基本药物目录(2015 年版)与世界卫生组织基本药物标准清单(第 19 版)的比较分析。
Biomed Res Int. 2018 Jun 10;2018:7862306. doi: 10.1155/2018/7862306. eCollection 2018.

引用本文的文献

1
Incidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study.2016年至2022年中国南方20种罕见神经系统疾病的发病率和健康负担:一项基于医院的观察性研究。
Orphanet J Rare Dis. 2025 Apr 8;20(1):163. doi: 10.1186/s13023-025-03704-5.
2
Epidemiology and distribution of 207 rare diseases in China: A systematic literature review.中国207种罕见病的流行病学与分布:一项系统文献综述
Intractable Rare Dis Res. 2024 May 31;13(2):73-88. doi: 10.5582/irdr.2024.01001.
3
Current situation and prospect for the diagnosis and treatment of pediatric critical rare diseases in China.
中国儿童危急罕见病的诊断与治疗现状及展望
Pediatr Investig. 2024 Feb 21;8(1):66-71. doi: 10.1002/ped4.12419. eCollection 2024 Mar.
4
Long way to go: Progress of orphan drug accessibility in China from 2017 to 2022.任重道远:2017年至2022年中国罕见病药物可及性进展
Front Pharmacol. 2023 Mar 8;14:1138996. doi: 10.3389/fphar.2023.1138996. eCollection 2023.
5
Incidence and prevalence of 121 rare diseases in China: Current status and challenges: 2022 revision.中国121种罕见病的发病率和患病率:现状与挑战:2022年修订版
Intractable Rare Dis Res. 2022 Aug;11(3):96-104. doi: 10.5582/irdr.2022.01093.
6
Current status and trend of clinical development of orphan drugs in China.中国孤儿药临床开发的现状和趋势。
Orphanet J Rare Dis. 2022 Jul 27;17(1):294. doi: 10.1186/s13023-022-02440-4.
7
Incidence and cost of haemolytic uraemic syndrome in urban China: a national population-based analysis.中国城市人群溶血尿毒综合征的发病及费用:一项基于全国人口的分析。
BMC Nephrol. 2022 Mar 30;23(1):122. doi: 10.1186/s12882-022-02746-2.
8
The definition of rare disease in China and its prospects.中国罕见病的定义及其前景。
Intractable Rare Dis Res. 2022 Feb;11(1):29-30. doi: 10.5582/irdr.2022.01034.
9
Incidence and prevalence of 121 rare diseases in China: Current status and challenges.中国121种罕见病的发病率和患病率:现状与挑战
Intractable Rare Dis Res. 2019 May;8(2):89-97. doi: 10.5582/irdr.2019.01066.